Perrin Conferences, the established leader in joint plaintiff and defense litigation conferences, is proud to present its inaugural Opioid Litigation Conference on June 28, 2018 at the Omni Dallas Hotel in Dallas, TX. View conference details and register at http://www.perrinconferences.com.
WAYNE, PA. (PRWEB) MAY 07, 2018
The Opioid Litigation Conference will be co-chaired by Jeffrey B. Simon, Esq., founding shareholder of Simon Greenstone Panatier Bartlett, PC and Mark Cheffo, Esq., a partner at Quinn Emanuel Urquhart & Sullivan, LLP. Mr. Simon is at the forefront of the opioid epidemic. He is widely quoted in the media for his expertise and was featured in a recent CNN article equating having the antidote naloxone at the ready to having a CPR kit available for an emergency.
Attendees will have the opportunity to hear from an array of high-level speakers on topics related to opioid use and litigation, including leading medical experts, plaintiff and defense attorneys, insurance professionals, and consultants such as:
The conference is designed to enhance the dialogue between all parties affected by the opioid epidemic. Some of the topics will include:
In addition to offering CLE accreditation, this conference offers attendees an exclusive information exchange and networking opportunity in an environment of collaboration and learning.
For more information, registration and hotel accommodations, please visit http://www.PerrinConferences.com.
About Perrin Conferences
As the leading national provider of joint plaintiff/defendant litigation conferences, Perrin Conferences offers comprehensive and specialized continuing legal education (CE/CLE) in an atmosphere of learning, networking and sharing. The company’s conferences attract influential leaders and foremost talent in the legal industry to discuss current topics in litigation through mock trials, presentations and webinars, setting the standard in professional litigation education and networking…